US Patent Issued to Saitama Medical University on Oct. 14 for "Peripheral blood biomarker for evaluating anti-tumor immune effect of radiation therapy" (Japanese Inventor)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,442,820, issued on Oct. 14, was assigned to Saitama Medical University (Saitama, Japan).

"Peripheral blood biomarker for evaluating anti-tumor immune effect of radiation therapy" was invented by Hiroshi Kagamu (Saitama, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a peripheral blood biomarker for evaluating the antitumor immune effect of radiation therapy. Also provided is a method in which the composition of cell subpopulation in a sample obtained from a subject is used as an index for immune activation in the subject caused by a radiation therapy. By comparing, with a reference, the amount of CD4+ T cell subpopulation that correlat...